Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2021 Jul 27;15(7):e0009628. doi: 10.1371/journal.pntd.0009628

Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria

Johnson A Ojo 1, Samuel A Adedokun 1, Akeem A Akindele 1, Adedolapo B Olorunfemi 1, Olawumi A Otutu 1, Taiwo A Ojurongbe 2, Bolaji N Thomas 3, Thirumalaisamy P Velavan 4,5,, Olusola Ojurongbe 1,‡,*
Editor: Mike J Doenhoff6
PMCID: PMC8345861  PMID: 34314428

Abstract

Background

The risk of co-infection with Schistosoma haematobium and S. mansoni and the potential harmful effect on morbidity and control is enhanced by the overlapping distribution of both species in sub-Saharan Africa. Despite the reported high endemicity of both species in Nigeria, studies on the spread and effect of their mixed infection are limited. Therefore, a cross-sectional survey was conducted among school children in two communities in South-west Nigeria to investigate the prevalence of mixed human schistosome infection, intensity, and possible ectopic egg elimination.

Methods

Urine and stool samples were collected from consenting school children in Ilie and Ore communities of Osun State, Nigeria. Schistosoma haematobium eggs were detected in urine using the urine filtration technique, while S. mansoni eggs were detected in stool using the Kato–Katz thick smear technique.

Results

The study enrolled 466 primary and secondary school children (211; 45.3% males vs. 255; 54.7% females; mean age 11.6 ± 3.16 years). The overall prevalence of schistosomiasis was 40% (185/466), with 19% (89/466) recording single S. haematobium infection while 9% (41/465) had a single S. mansoni infection. The geometric mean egg count for S. haematobium was 189.4 egg/10ml urine; 95% CI: range 115.9–262.9, while for S. mansoni, it was 115.7 epg; 95% CI: range 78.4–152.9. The prevalence of ectopic S mansoni (S. mansoni eggs in urine) was 4.7%, while no ectopic S. haematobium (S. haematobium eggs in stool) was recorded. Mixed infection of S. haematobium/S. mansoni had a prevalence of 9.5% (44/466). More females (54.5%) presented with S. haematobium/S. mansoni co-infection. For both parasites, males had higher infection intensity, with a significant difference observed with S. haematobium (p = 0.0004). Hematuria was significant in individuals with single S. haematobium infection (p = 0.002), mixed ectopic S. haematobium/S. mansoni (p = 0.009) and mixed S. haematobium/S. mansoni/ectopic S. mansoni (p = 0.0003).

Conclusions

These findings suggest the probability of interspecific interactions between S. haematobium and S. mansoni. Scaling up of mass administration of praziquantel and control measures in the study areas is highly desirable.

Author summary

In sub-Saharan Africa, human schistosomiasis is a neglected disease of public health concern caused mostly by Schistosoma haematobium and Schistosoma mansoni. The overlapping range of both species in Africa considerably increases the chance of co-infection. School-aged children are the most vulnerable, as they participate in water contact activities that expose them to free-swimming cercariae released by infected snail species in freshwater. This study examined the probable mixed human Schistosoma infections and associated disease variables in school children in the communities of Ilie and Ore in southwest Nigeria. This study reveals a high prevalence of mixed S. haematobium and S. mansoni, and ectopic S. mansoni eggs (S. mansoni eggs in urine) elimination, highlighting the possible ongoing control challenges in this area. Furthermore, this study indicates that some form of inter-specific interaction exists between S. haematobium and S. mansoni, and may produce potentially significant consequences for developing morbidity in the study areas.

Introduction

Schistosomiasis, a neglected tropical disease targeted for elimination by the World Health Organization (WHO) [1], is a significant public health problem, with Nigeria [24] ranking first among African countries with the highest disease burden [5]. The disease caused by the genus Schistosoma is responsible for the most obvious reduction in age-standardized years lived with disability (YLD) between 2006 and 2016 [6]. The most affected group are school-aged children, involved in water contact activities that brings them in contact with the free-swimming cercariae, released from infected snail species in freshwater [3,7]. The disease is present in 78 countries, affecting more than 250 million people annually, presenting with two major forms; a urogenital disease caused by S. haematobium and intestinal disease caused by S. mansoni, S. japonicum, S. mekongi, and S. intercalatum. S. haematobium (Sh) and S. mansoni (Sm) are the two major species endemic in sub-Saharan Africa, along with a few cases of S. intercalatum, localized in rain forest areas of Central Africa [1,8].

Urogenital schistosomiasis is associated with outcomes, such as hematuria, bladder cancer, and hydronephrosis, while the chronic intestinal disease is characterized by hepatomegaly, splenomegaly, and progressive periportal fibrosis resulting in portal hypertension, esophageal varices, liver surface irregularities, portal-systemic venous shunts, and hematemesis [9,10]. The impaired physical and cognitive development arising from chronic infection among children is a major concern in many parts of the world [11]. The risk of co-infection with Sh and Sm is greatly enhanced by the overlapping distribution of both species in Africa [12]. However, there is a lack of information on the determinants, distribution and the impact of such mixed infections on endemic populations. Results from co-infection in experimental models show the two species could form heterologous male-female pairs, with the male carrying the female to its preferred site for oviposition and the female producing eggs characteristic of her species in an uncharacteristic site [13,14]. This phenomenon, referred to as hybridization, is believed to be responsible for ectopic egg elimination resulting in the detection of Sm eggs in urine or Sh eggs in feces, in areas where mixed infection occurs [15,16], and suggestive of possible sexual interaction in nature between Sh and Sm. Hybridization of human schistosomes species was recently observed in France from a patient who had just returned from Côte d’Ivoire [17,18]. It is believed that disease epidemiology and phenotypic characteristics could be altered by hybridization, which could ultimately affect the parasite’s transmission and host compatibility [19,20].

An increasing number of foci where co-infections between Sh and Sm occur has been reported in some parts of Africa [15,2123]. In some of these foci, differences in schistosomiasis-associated morbidity, as well as infection intensity, have been reported between single and mixed infections [23]. The presence of one species may alter the course of infection or disease caused by the other, and such interactions could arise through competition for nutrients or mates or immune-mediated mechanisms, including cross-reactive immune responses. Also, an increase in S. mansoni infection has been observed after praziquantel treatment in co-endemic areas [23,24]. These interspecific interactions of Sh/Sm, although not fully understood, may have important implications on epidemiology, associated morbidity, and control measures, including PZQ treatment. Information on the occurrence and prevalence of mixed infections will help us answer critical questions on the underlying mechanisms toward morbidity and develop effective strategies for preventing and controlling schistosomiasis in co-endemic areas. Both Sh and Sm occur in Nigeria, with Sh having a higher prevalence. While several studies have reported both species in the same foci, there has been very little information on the prevalence and impact of mixed Sh and Sm infection and the possible ectopic egg elimination.

In developing countries, children aged 5–17 years are at the highest risk of infection and are the most infected group targeted with preventive mass chemotherapy. Also, in the context of the current WHO strategies for controlling and eliminating schistosomiasis, our study focused on school-aged children. Therefore, this study presents a cross-sectional report among school children to investigate possible mixed Schistosoma infections and associated disease covariates in two schistosomiasis endemic communities in Nigeria.

Material and methods

Ethics statement

The Ethical Review Committee, Osun State Ministry of Health approved the study (approval number OSHREC/PRS/569T/131). Verbal and/or written informed consent was obtained from the parents/guardians and assent from the participants before they were recruited.

Study site

The study was conducted in Ore and llie communities, Osun State, Nigeria. The two communities are located very closely on latitude 4°34’ and 4°36’E, and Longitude 7°56’ and 7°58’N, and only separated by a dam in the rain forest zone. The dam, owned and managed by the State Water Corporation, Olorunda local government area, southwest Nigeria, is the breeding site of Schistosoma due to the abundant presence of the snail intermediate host in the dam. These communities depend on the dam for their domestic water supply, fishing, and other water-related activities. There have been previous reports of schistosome endemicity in these communities [25].

Study population, inclusion, and exclusion criteria

The study population consisted of primary and secondary school children aged 4–19 years attending Ore Community Primary and Secondary School and Ilie Community Primary and Secondary school. They are in Primary 2–5, Junior Secondary School 1–3, and Senior Secondary School 1–3. Participants with a history of being clinically ill during recruitment and those who used antischistosomal drugs in the last six months before the study and those whose parents refused to give informed consent and children who refused to give assent were excluded.

Study design and sample size calculation

The study design was cross-sectional and conducted between March 2018 and May 2019. Headteachers and principals of the selected primary and secondary schools were duly informed by the school board about the study. The significance of the study was highlighted to the teachers, parents and the school children before sample collection. The sample size was obtained using the formula for a cross-sectional study [26]. Using a prior prevalence of 37.5% among school children positive for schistosomiasis [25],a marginal error of 5%, and a type 1 error of 5%, a minimum sample of 289 school children was needed.

Sample collection

In all, 466 school children participated in this study. Individual demographic information was collected with a structured questionnaire, while two sterile, universal containers, individually labeled for urine and stool collection, were distributed to consenting school children. Instructions on the procedure for collecting urine and stool were given to the students to ensure that contamination was avoided. For each participant, one urine and stool sample were collected.

Parasitological examination

The presence of Sh eggs was detected using the urine filtration technique, as previously described [3]. Briefly, 10 ml of the freshly passed urine sample was pushed through a micro-filter membrane of 10–12 μm (MF, Whatman, New Jersey, USA) using a syringe. The micro-filter membrane was then carefully placed on a glass slide, mounted on a microscope, and examined using a light microscope’s low-power objective (10×). For stool analysis, two Kato–Katz thick smears were prepared using 41.7 mg templates of the stool material for each and microscopically examined for Sm and other intestinal parasites [27]. Slides were examined by two independent and experienced scientists. For quality control, 15% of all positive and negative slides were re-examined by a third independent microscopist who was blind to the first two scientist results. The Sh infection intensity was expressed as the number of eggs detected in 10ml of urine (eggs/10ml), while Sm infection intensity was expressed as the number of eggs detected per gram of feces (epg). The counted eggs were categorized into a light infection (1–99 epg for Sm and 1–49 eggs per 10ml of urine for Sh), moderate (100–399 epg for Sm), and heavy infections (≥400epg for Sm and ≥ 50 eggs per 10ml of urine for Sh) [28]. Single infection was defined as passing eggs of only one species, and mixed infection as passing eggs of both Sm and Sh. The incidence of ectopic egg excretion was measured qualitatively (positive/negative). Ectopic egg elimination refers to detecting schistosomal eggs via the unusual route–i.e., Sh eggs in feces or Sm eggs in urine. Overall Sm infection refers to both mixed and single Sm infections. Overall Sh infection includes both mixed and single Sh infections. Each child found to be positive for any of the schistosome species was treated with 40mg/kg praziquantel by the study team.

Data analysis

Data were double entered into an excel sheet, cleaned, and then analyzed using IBM Statistical Package for Social Sciences (SPSS) for Windows version 20 (SPSS, Inc., Armonk, USA). Data were described using percentages, geometric means, and 95% confidence interval. The egg output data was 10 log-transformed to normalize skewed egg distribution. Geometric means of egg count (GM epg or eggs per 10 ml of urine) were computed for microscopically positive individuals, and intensity of infection was analyzed. The χ-square test was used to evaluate the association between infection status (Sm, Sh, and mixed infection) and disease covariates (sex, age, etc.). The independent-samples t-test was used to compare GM infection intensities with age and sex.

Results

A sample comprising 5 grams of feces and 10 ml of urine was obtained from 466 primary and secondary school children who participated in the study. Complete parasitological data were also obtained from all these participants. The participants consisted of 211 (45.3%) males and 255 (54.7%) females with a mean age of 11.6±3.16 years. The overall mean weight and height are 31.2±9.60kg and 1.41±0.78m, respectively. According to age group, the breakdown of the infection showed that the older age group (12–19 years) was generally more infected except for children with mixed ectopic Sm/ Sh infection. In all the age group comparisons, no significant difference was observed. Similarly, no significant difference was observed between gender and infection prevalence, with females having a higher proportion of Sh (57.3%), Sm (58.5%) single infections, and Sh/Sm mixed infection (54.5%) while males had higher prevalence for the mixed infections of ectopic Sm/Sh (80.0%) and ectopic Sm/Sh/Sm (54.5%) (Table 1). 33.7% of the participants positive for Sh had blood in their urine, while 66.3% were Sh positive but without blood in their urine, and the difference was statistically significant (p = 0.002). Similarly, the proportion of the mixed infections of ectopic Sm/Sh (p = 0.009) and ectopic Sm/Sh/Sm (p = 0.0003) had a statistically significant effect on the proportion of participants with blood in their urine. The mean weight and the mean height of the study population are shown in Table 1. Mean weight and mean heights of positive and negative participants showed no statistically significant difference. The overall prevalence of schistosomiasis in the study was 40% (185/466). Single Sh infection among the participants was 19% (89/466) with a geometric egg count of 189.4egg/10mls (95%CI: 115.9–262.9), while 9% (41/465) had single Sm infection with a geometric egg count of 115.7 epg (95%CI: 78.4–152.9). Mixed Sh/Sm infection was recorded in 9.5% (44/466) of the study population. Mixed ectopic Sm occurring along with Sh (Fig 1) was recorded in 4.5% (21/466) of the study population while 1(0.2%) participant had a single ectopic Sm infection. The occurrence and distribution of Schistosoma infection are shown in Table 2. An overall prevalence of 31% and 10% for Sh and Sm, respectively, was observed.

Table 1. General characteristics and prevalence of human schistosomiasis in the study population.

Characteristics Total Population Sh (single infection) n = 89 Sm (single infection) n = 41 Sh/Sm (Mixed infection) n = 33 ESm (single infection) n = 1 ESm/Sh (Mixed infection) n = 10 Sh/Sm/ ESm (Mixed infection) n = 11
Mean age ± SD 11.6±3.16 12.0±3.10 12.5±2.70 12.3±2.50 - 11.3±2.21 12.8±3.5
Mean weight ± SD 31.2±9.60 32.9±9.96 32.0±9.10 33.8±7.74 29.1±5.07 33.4±10.40
Mean Height± SD
Age group
1.41±0.78 1.41±0.16 1.69±1.98 1.40±0.15 1.37±0.07 1.39±0.16
4–11 years (%) 221 (47.4) 40 (45.0) 15 (36.6) 11 (33.3) 0 6 (60.0) 4 (36.4)
12–19 years (%) 245 (52.6) 49 (55.1) 26 (63.4) 22 (66.7) 1 (100) 4 (40.0) 7 (63.6)
p-value 0.638 0.189 0.105 - 0.528 0.550
Sex
Male (%) 211 (45.3) 38 (42.7) 17 (41.5) 15 (45.5) 0 8 (80.0) 6 (54.5)
Female (%) 255 (54.7) 51 (57.3) 24 (58.5) 18 (54.5) 1 (100) 2 (20.0) 5 (45.5)
p-value 0.636 0.627 1.000 - 0.050 0.556
Blood in Urine
Present 98 (21.0) 30 (33.7) 6 (14.6) 11 (33.3) 0 6 (60.0) 8 (72.7)
Absent 368 (79.0) 59 (66.3) 35 (85.4) 22 (66.7) 4 (40.0) 3 (27.3)
p-value 0.002* 0.421 0.079 0.009* 0.0003*

Key: Sh: Schistosoma haematobium; Sm: Schistosoma mansoni; ESm: Ectopic Schistosoma mansoni

*Significant p<0.05

Fig 1.

Fig 1

Ectopic egg elimination of S. mansoni in the urine of one of the study participants: A: S. mansoni egg; B, C, D: S. haematobium.

Table 2. Schistosomal infection prevalence and intensities.

Sm infection Sm infection Prevalence n = 466 (%) Sh infection intensity Sm infection intensity
Urine Stool Urine stool GM egg/ 10 ml (95% CI) GM epg (95% CI)
Positive participants 185 (40.0)
Single infection + - - - 89 (19.1) 189.4 115.9–262.9
- + - - 0
- - + - 1 (0.2)
- - - + 41 (9.0) 115.7 78.4–152.9
Mixed Infections 44 (9.5) 668.6 395.4–941.8 229.2 100.5–357.9
ESm Infection + 21 (4.7)
Negative participants 281 (60.4)
Overall Sh infections 143 (30.8) 399.4 263.7–535.2
Overall Sm infections 85 (18.3) 174.4 105.6–243.3

Key: Sh: Schistosoma haematobium; Sm: Schistosoma mansoni; ESm: Ectopic Schistosoma mansoni

+ = Positive;— = Negative

The association between ectopic Sm egg elimination and infection intensities of Sh and Sm is shown in Table 3. A high prevalence of ectopic Sm egg was observed in high infection intensities of both Sh (18%) and Sm (15.6%), producing a significant association in both cases. Fig 2 shows the relationship between age prevalence and infection intensity in the study population. Age group 12–19 years recorded a higher prevalence of Sh, Sm, and ectopic Sm infection than the younger age group (4–11 years), but the difference in all cases was not statistically significant. In both Sh and Sm, the younger age group (4–11 years) had higher infection intensity and was statistically significant (p = 0.016) in the Sm group. The pattern was different for the ectopic Sm infection group as the older age group recorded the higher infection intensity, but the difference was not statistically significant (Fig 2).

Table 3. Relation between ectopic Schistosoma mansoni eggs in urine and intensities of S. haematobium egg in urine and S.mansoni egg in stool.

Intensities of Sh in urine (eggs/10ml) Sm eggs in urine
N Cases Prevalence (%)
0 323 1 0.3
1–9 0 0 0
10–49 32 1 3.1
≥ 50 111 20 18
Total 466 22
Intensity of Sm in stool (epg)
0 381 11 2.9
1–99 53 6 11.3
≥ 100 32 5 15.6
Total 466 22

Key: Sh: Schistosoma haematobium; Sm: Schistosoma mansoni

Fig 2. Age-prevalence and intensity curves for schistosomiasis.

Fig 2

The bars indicate overall infection prevalence per age group. Lines indicate mean log-transformed infection intensities among positive subjects. A: S. haematobium infection; Age vs prevalence p>0.05; infection intensity vs age p = 0.55. B: S. mansoni infection; Age vs prevalence p = 0.016*; infection intensity vs age p = 0.33. C: Ectopic egg (S. mansoni in urine) infection; Age vs prevalence p>0.05; infection intensity vs age p = 0.059.

The relationship between sex and infection intensity in the study population is shown in Fig 3. Females were more infected with both Sh and Sm, but the difference was not statistically significant. On the other hand, males recorded more ectopic Sm infection, but the difference was not statistically significant. For both Sh and Sm, males had higher infection intensity, and the difference was significant in those infected with Sh (p = 0.0004). In ectopic Sm, females had higher infection intensity, but the difference was not statistically significant (Fig 3).

Fig 3. Sex-prevalence and intensity curves for schistosomiasis.

Fig 3

The bars indicate overall infection prevalence per sex. Lines indicate mean log-transformed infection intensities among positive subjects. A: S. haematobium infection; Sex vs prevalence p = 0.487; infection intensity vs sex p = 0.004*. B: S. mansoni infection; Age vs prevalence p = 0.883; infection intensity vs age p = 0.797. C: Ectopic egg (S. mansoni in urine) infection; Age vs prevalence p = 0.073; infection intensity vs age p = 0.289.

Discussion

We present the analysis of mixed Sh and Sm infections and the ectopic egg elimination of schistosome eggs in school children in Osun State, Nigeria. The study revealed a high prevalence of both Sh and Sm infections among school children in Ilie and Ore communities of Osun State, Nigeria. The overall prevalence of schistosomiasis was 40%, and as expected, the prevalence of Sh (31%) was significantly higher than Sm (10%) (p<0.05). An earlier report had shown widespread urinary schistosomiasis in the Niger River basin, the Southwest, the Central and Northern Highlands, and Lake Chad. At the same time, intestinal schistosomiasis was less prevalent and widespread in Nigeria [29]. Across the different regions of Nigeria, mixed Sh and Sm infection prevalence ranges from 60.8 to 4.8% and 8.9 to 2.9%, respectively [3033]. The high prevalence of both Sh and Sm reported in this study highlights the possible ongoing control challenges in this area. Also worrisome is the observation that 10% of the school children were co-infected with both Sh and Sm. Inter-specific parasite interactions in areas with mixed species infections have been predicted to impact host morbidity significantly. For example, lower liver morbidity has been reported in individuals with mixed infection than those with single Sm infections, and higher bladder morbidity reported in those with mixed compared to those with single Sh infections [23]. The lowering impact of liver morbidity in individuals with mixed infections was suggested to be caused by the hybrid eggs produced by the mating of Sh males with Sm females. For instance, the deposition of such eggs in the urinary oviposition site (ectopic egg elimination) reduces the amount of classical Sm eggs capable of inducing liver morbidity [23,34]. While this study observed Sm eggs in urine, Sh eggs were not recovered in the stool. By implication, the high prevalence and high intensity of Sh co-infection with Sm in this study may aggravate the associated Sh bladder morbidity. To clarify this observation, a future study must investigate the impact of mixed Sh and Sm co-infections on both liver and bladder morbidity and other schistosome-related clinical manifestations in the study area.

The occurrence of S. mansoni lateral spined egg (4.7%) ectopic excretion was observed in the urine of study participants. Ectopic egg elimination (Sh eggs in feces and Sm eggs in urine) has been reported in endemic areas where both schistosomes co-exist [15,35]. The presence of ectopic infection in sympatry warrants intensification of monitoring (diagnosis) and control to avert the emergence of or curtail the spread of a possible hybrid of S. mansoni and S. haematobium. Hybridization resulting from closely related sister species of schistosomes like S. bovis (that causes intestinal schistosomiasis in ruminants) and Sh, has been reported in Senegal [36,37] and is also linked to the outbreak of schistosomiasis in Corsica, France [19]. Similarly, hybridization between the two major human schistosomes, Sh and Sm, which used to be very rare or not taken into consideration, possibly because of the assumption of the significant phylogenetic distance, has now been described in Senegal [38] and in France in a patient that originated from Côte d’Ivoire [18]. Although our study did not conduct a hybridization study, the occurrence of ectopic Sm could imply hybridization between the two human schistosomes as previously reported in Cameroon [15,16] and may warrant further investigation. The emergence of hybrids may negatively impact schistosomiasis control as they are well adapted to intermediate hosts, modify the epidemiology of the disease [17,39,40], spread to new areas, and become invasive populations [19].

Significantly, we observed more individuals within the age groups 4-11years and 12–19 years with lower infection intensities among those concurrently infected with both species compared to single infections, contrary to reports elsewhere [34,35]. The heterospecific interaction between Sm and Sh and the high egg output in the 4–11 years age range could have severe or moderate consequences on the associated morbidity outcomes [15,23,34]. Potentially, heterospecific pairs could determine the egg type produced, its pathogenicity, and affect disease transmission. Therefore, additional information is needed about egg production and egg viability for concurrent infections. Further research in other endemic communities where there is an overlap of the two species is recommended to better understand the biomedical and public health consequences of mixed infection.

The age-related prevalence of schistosomiasis has been shown to increase as the age increases, peaking in adolescence and lowering among adults [41]. Unfortunately, adults were not included in this study, making it impossible to investigate this age-infection profile. Nonetheless, the adolescent group was significantly more infected but had a lower intensity of infection than the younger age group in this study. The older children are engaged in more water contact activity leading to the observed higher prevalence, but possess a long history of exposure and higher parasite-specific acquired immunity leading to lower infection intensity [41]. The prevalence of Sh and Sm was higher in females, and the males, on the other hand, had a higher prevalence of mixed infections. Both Sh and Sm recorded higher infection intensity in males, while for mixed infection, the infection intensity was higher in females. Earlier studies have documented heavier infection in males than females in Sh and Sm, contrary to our observation [42,43], although others have agreed [44,45]. Socio-cultural or behavioral factors focusing mainly on differences in the water contact pattern between males and females are generally implicated in the frequently observed gender-related differences in prevalence and infection intensity [3], although susceptibility factors like hormonal differences and genetic factors cannot be ruled out. The explanation for the differences in gender-related prevalence in this study may not be precise, but we speculate that females had higher water contact activities with a considerably longer duration of body exposure. The higher infection intensity observed in males may warrant further investigation as it is generally believed that high testosterone levels in males will significantly lower the infection prevalence and intensity [46]. Since this is not the focus of our study, it is clear that more studies will be needed to decipher the impact of gender on infection prevalence and intensity in our study area.

A close association was observed between hematuria and Sh eggs in the urine, similar to the reports of Ekpo et al. (2010) [4]. The close relationship between hematuria and the presence of eggs in the urine could be explored to assess urinary schistosomiasis in communities (after eliminating other conditions that could precipitate blood in urine) as it may also be helpful in determining endemicity in areas where urine microscopy might not be possible.

Understanding the exact relationship between mixed infection and infection intensity is crucial, as increased egg loads can significantly affect morbidity [12]. Higher Sh and Sm infection intensities were recorded in mixed than in single infections, and a positive association between Sh and Sm infections was reported in this study. While some studies have reported higher infection intensities in mixed infections [35,47], other studies on a larger scale have reported inconsistent results [48,49]. Possibly, the relationship between mixed infection and infection intensity varies according to local differences in Sm and Sh transmission. Therefore, larger sample size in different locations might be needed to accurately decipher the influence of mixed schistosome infection on the infection intensity.

The collection of only one stool and urine sample from each study participant in this study may have underestimated the infection prevalence and intensity. It is recommended that two or more consecutive samples should be collected for increased accuracy. Unfortunately, due to logistics and cost, multiple samples could not be collected in this study. However, we posit that the current observations provide enough evidence to encourage further studies and influence decision-making. We recommend further research in other endemic communities where there is an overlap of the two species to better understand the biomedical and public health consequences by including some clinical examinations (e.g., palpation and ultrasonography) not considered in this study.

In summary, this study reveal a high prevalence of mixed Sh and Sm; and ectopic Sm eggs elimination in Ilie and Ore communities of Osun State Nigeria. Furthermore, this study indicates that some form of inter-specific interaction exists between Sh and Sm, and may produce potentially significant consequences for developing morbidity in the study areas. Therefore, further study on the impact of mixed Sh and Sm infections on both liver and bladder morbidities and scaling up of mass administration of praziquantel and control efforts in the study areas are highly recommended.

Acknowledgments

The authors are sincerely grateful to all consenting participants, their parents, and all the teachers for their cooperation. OO appreciate the continuous support of Alexander von Humboldt Foundation, Germany. The image of the egg of Schistosoma was captured with the assistance of Dr. Adrian Streit in his laboratory at Max Planck Institute for Evolutionary Biology, Tuebingen

Data Availability

The data is available at https://data.mendeley.com/datasets/ddn8k3b5jj/1 doi: 10.17632/ddn8k3b5jj.1.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.WHO. Schistosomiasis. 2020 [cited 11 May 2020]. Available: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
  • 2.Ezeh CO, Onyekwelu KC, Akinwale OP, Shan L, Wei H. Urinary schistosomiasis in Nigeria: a 50 year review of prevalence, distribution and disease burden. Parasite Paris Fr. 2019;26: 19. doi: 10.1051/parasite/2019020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ojurongbe O, Sina-Agbaje OR, Busari A, Okorie PN, Ojurongbe TA, Akindele AA. Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria. Infect Dis Poverty. 2014;3: 30. doi: 10.1186/2049-9957-3-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ekpo UF, Laja-Deile A, Oluwole AS, Sam-Wobo SO, Mafiana CF. Urinary schistosomiasis among preschool children in a rural community near Abeokuta, Nigeria. Parasit Vectors. 2010;3: 58. doi: 10.1186/1756-3305-3-58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6: 411–425. doi: 10.1016/S1473-3099(06)70521-7 [DOI] [PubMed] [Google Scholar]
  • 6.King CH, Galvani AP. Underestimation of the global burden of schistosomiasis. The Lancet. 2018;391: 307–308. doi: 10.1016/S0140-6736(18)30098-9 [DOI] [PubMed] [Google Scholar]
  • 7.Ciddio M, Mari L, Sokolow SH, De Leo GA, Casagrandi R, Gatto M. The spatial spread of schistosomiasis: A multidimensional network model applied to Saint-Louis region, Senegal. Adv Water Resour. 2017;108: 406–415. doi: 10.1016/j.advwatres.2016.10.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kabore A, Ibikounle M, Tougoue JJ, Mupoyi S, Ndombe M, Shannon S, et al. Initiating NTD programs targeting schistosomiasis and soil-transmitted helminthiasis in two provinces of the Democratic Republic of the Congo: Establishment of baseline prevalence for mass drug administration. Acta Trop. 2017;166: 177–185. doi: 10.1016/j.actatropica.2016.11.023 [DOI] [PubMed] [Google Scholar]
  • 9.Barsoum RS. Urinary Schistosomiasis: Review. J Adv Res. 2013;4: 453–459. doi: 10.1016/j.jare.2012.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4: 65–79. doi: 10.1177/1742395307084407 [DOI] [PubMed] [Google Scholar]
  • 11.Ezeamama AE, Bustinduy AL, Nkwata AK, Martinez L, Pabalan N, Boivin MJ, et al. Cognitive deficits and educational loss in children with schistosome infection—A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12: e0005524. doi: 10.1371/journal.pntd.0005524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet Lond Engl. 2006;368: 1106–1118. doi: 10.1016/S0140-6736(06)69440-3 [DOI] [PubMed] [Google Scholar]
  • 13.Khalil SB, Mansour NS. Worm development in hamsters infected with unisex and cross-mated Schistosoma mansoni and Schistosoma haematobium. J Parasitol. 1995;81: 8–11. [PubMed] [Google Scholar]
  • 14.Webster BL, Southgate VR, Tchuem Tchuenté LA. Mating interactions between Schistosoma haematobium and S. mansoni. J Helminthol. 1999;73: 351–356. [PubMed] [Google Scholar]
  • 15.Cunin P, Tchuem Tchuenté L-A, Poste B, Djibrilla K, Martin PMV. Interactions between Schistosoma haematobium and Schistosoma mansoni in humans in north Cameroon. Trop Med Int Health TM IH. 2003;8: 1110–1117. doi: 10.1046/j.1360-2276.2003.01139.x [DOI] [PubMed] [Google Scholar]
  • 16.Ratard RC, Ndamkou CN, Kouemeni LE, Ekani Bessala MM. Schistosoma mansoni eggs in urine. J Trop Med Hyg. 1991;94: 348–351. [PubMed] [Google Scholar]
  • 17.Depaquit J, Akhoundi M, Haouchine D, Mantelet S, Izri A. No limit in interspecific hybridization in schistosomes: observation from a case report. Parasite Paris Fr. 2019;26: 10. doi: 10.1051/parasite/2019010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Le Govic Y, Kincaid-Smith J, Allienne J-F, Rey O, de Gentile L, Boissier J. Schistosoma haematobium-Schistosoma mansoni Hybrid Parasite in Migrant Boy, France, 2017. Emerg Infect Dis. 2019;25: 365–367. doi: 10.3201/eid2502.172028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boissier J, Grech-Angelini S, Webster BL, Allienne J-F, Huyse T, Mas-Coma S, et al. Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. Lancet Infect Dis. 2016;16: 971–979. doi: 10.1016/S1473-3099(16)00175-4 [DOI] [PubMed] [Google Scholar]
  • 20.Tchuem Tchuenté L-A, Southgate VR, Jourdane J, Webster BL, Vercruysse J. Schistosoma intercalatum: an endangered species in Cameroon? Trends Parasitol. 2003;19: 389–393. doi: 10.1016/s1471-4922(03)00193-4 [DOI] [PubMed] [Google Scholar]
  • 21.Abdel-Wahab MF, Yosery A, Narooz S, Esmat G, el Hak S, Nasif S, et al. Is Schistosoma mansoni replacing Schistosoma haematobium in the Fayoum? Am J Trop Med Hyg. 1993;49: 697–700. doi: 10.4269/ajtmh.1993.49.697 [DOI] [PubMed] [Google Scholar]
  • 22.Garba A, Labbo R, Tohon Z, Sidiki A, Djibrilla A. Emergence of Schistosoma mansoni in the Niger River valley, Niger. Trans R Soc Trop Med Hyg. 2004;98: 296–298. doi: 10.1016/S0035-9203(03)00070-1 [DOI] [PubMed] [Google Scholar]
  • 23.Koukounari A, Donnelly CA, Sacko M, Keita AD, Landouré A, Dembelé R, et al. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. BMC Infect Dis. 2010;10: 1–14. doi: 10.1186/1471-2334-10-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ernould JC, Ba K, Sellin B. Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus. Acta Trop. 1999;73: 143–152. doi: 10.1016/s0001-706x(99)00013-3 [DOI] [PubMed] [Google Scholar]
  • 25.Awosolu OB, Shariman YZ, Haziqah M T F, Olusi TA. Will Nigerians Win the War Against Urinary Schistosomiasis? Prevalence, Intensity, Risk Factors and Knowledge Assessment among Some Rural Communities in Southwestern Nigeria. Pathog Basel Switz. 2020;9. doi: 10.3390/pathogens9020128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Charan J, Biswas T. How to Calculate Sample Size for Different Study Designs in Medical Research? Indian J Psychol Med. 2013;35: 121–126. doi: 10.4103/0253-7176.116232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14: 397–400. [PubMed] [Google Scholar]
  • 28.Coulibaly JT, N’Gbesso YK, N’Guessan NA, Winkler MS, Utzinger J, N’Goran EK. Epidemiology of Schistosomiasis in Two High-Risk Communities of South Côte d’Ivoire with Particular Emphasis on Pre-School–Aged Children. Am J Trop Med Hyg. 2013;89: 32–41. doi: 10.4269/ajtmh.12-0346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Jones I. The History of Schistosomiasis in Nigeria. http://schisto.stanford.edu/pdf/Nigeria.pdf. 2015: 2.
  • 30.Adeniran AA, Mogaji HO, Aladesida AA, Olayiwola IO, Oluwole AS, Abe EM, et al. Schistosomiasis, intestinal helminthiasis and nutritional status among preschool-aged children in sub-urban communities of Abeokuta, Southwest, Nigeria. BMC Res Notes. 2017;10: 637. doi: 10.1186/s13104-017-2973-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Aribodor DN, Bassey SA, Yoonuan T, Sam-Wobo SO, Aribodor OB, Ugwuanyi IK. Analysis of Schistosomiasis and soil-transmitted helminths mixed infections among pupils in Enugu State, Nigeria: Implications for control. Infect Dis Health. 2019;24: 98–106. doi: 10.1016/j.idh.2018.12.003 [DOI] [PubMed] [Google Scholar]
  • 32.Dawaki S, Al-Mekhlafi HM, Ithoi I, Ibrahim J, Abdulsalam AM, Ahmed A, et al. Prevalence and Risk Factors of Schistosomiasis among Hausa Communities in Kano State, Nigeria. Rev Inst Med Trop Sao Paulo. 2016;58: 54. doi: 10.1590/S1678-9946201658054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Singh K, Muddasiru D, Singh J. Current status of schistosomiasis in Sokoto, Nigeria. Parasite Epidemiol Control. 2016;1: 239–244. doi: 10.1016/j.parepi.2016.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Meurs L, Mbow M, Vereecken K, Menten J, Mboup S, Polman K. Bladder Morbidity and Hepatic Fibrosis in Mixed Schistosoma haematobium and S. mansoni Infections: A Population-Wide Study in Northern Senegal. PLoS Negl Trop Dis. 2012;6. doi: 10.1371/journal.pntd.0001829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Meurs L, Mbow M, Vereecken K, Menten J, Mboup S, Polman K. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal. Int J Parasitol. 2012;42: 305–311. doi: 10.1016/j.ijpara.2012.02.002 [DOI] [PubMed] [Google Scholar]
  • 36.Huyse T, Webster BL, Geldof S, Stothard JR, Diaw OT, Polman K, et al. Bidirectional Introgressive Hybridization between a Cattle and Human Schistosome Species. PLOS Pathog. 2009;5: e1000571. doi: 10.1371/journal.ppat.1000571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Webster BL, Diaw OT, Seye MM, Webster JP, Rollinson D. Introgressive hybridization of Schistosoma haematobium group species in Senegal: species barrier break down between ruminant and human schistosomes. PLoS Negl Trop Dis. 2013;7: e2110. doi: 10.1371/journal.pntd.0002110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Huyse T, Van den Broeck F, Hellemans B, Volckaert F a. M, Polman K. Hybridisation between the two major African schistosome species of humans. Int J Parasitol. 2013;43: 687–689. doi: 10.1016/j.ijpara.2013.04.001 [DOI] [PubMed] [Google Scholar]
  • 39.Boon NAM, Van Den Broeck F, Faye D, Volckaert FAM, Mboup S, Polman K, et al. Barcoding hybrids: heterogeneous distribution of Schistosoma haematobium × Schistosoma bovis hybrids across the Senegal River Basin. Parasitology. 2018;145: 634–645. doi: 10.1017/S0031182018000525 [DOI] [PubMed] [Google Scholar]
  • 40.Sene-Wade M, Marchand B, Rollinson D, Webster BL. Urogenital schistosomiasis and hybridization between Schistosoma haematobium and Schistosoma bovis in adults living in Richard-Toll, Senegal. Parasitology. 2018;145: 1723–1726. doi: 10.1017/S0031182018001415 [DOI] [PubMed] [Google Scholar]
  • 41.Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CMR, Maizels RM. Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis. 2008;198: 167–175. doi: 10.1086/589511 [DOI] [PubMed] [Google Scholar]
  • 42.Kabatereine NB, Kemijumbi J, Ouma JH, Kariuki HC, Richter J, Kadzo H, et al. Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. Trans R Soc Trop Med Hyg. 2004;98: 711–718. doi: 10.1016/j.trstmh.2004.06.003 [DOI] [PubMed] [Google Scholar]
  • 43.Moira AP de Fulford AJC, Kabatereine NB Ouma JH, Booth M Dunne DW. Analysis of Complex Patterns of Human Exposure and Immunity to Schistosomiasis mansoni: The Influence of Age, Sex, Ethnicity and IgE. PLoS Negl Trop Dis. 2010;4. doi: 10.1371/journal.pntd.0000820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Goselle NO, Anegbe D, Imandeh GN, Dakul DA, Onwuliri ACF, Abba OJ, et al. Schistosoma mansoni infections amongst school children in Jos, Nigeria. Sci World J. 2010;5. doi: 10.4314/swj.v5i1.61485 [DOI] [Google Scholar]
  • 45.Tefera A, Belay T, Bajiro M. Epidemiology of Schistosoma mansoni infection and associated risk factors among school children attending primary schools nearby rivers in Jimma town, an urban setting, Southwest Ethiopia. PloS One. 2020;15: e0228007. doi: 10.1371/journal.pone.0228007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Nakazawa M, Fantappie MR, Freeman GL, Eloi-Santos S, Olsen NJ, Kovacs WJ, et al. Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol. 1997;85: 233–240. doi: 10.1006/expr.1997.4148 [DOI] [PubMed] [Google Scholar]
  • 47.Robert CF, Bouvier S, Rougemont A. Epidemiology of schistosomiasis in the riverine population of Lagdo Lake, northern Cameroon: mixed infections and ethnic factors. Trop Med Parasitol Off Organ Dtsch Tropenmedizinische Ges Dtsch Ges Tech Zusammenarbeit GTZ. 1989;40: 153–158. [PubMed] [Google Scholar]
  • 48.Ahmed ES, Daffalla A, Christensen NO, Madsen H. Patterns of infection and transmission of human schistosomiasis mansoni and schistosomiasis haematobium in White Nile Province, Sudan. Ann Trop Med Parasitol. 1996;90: 173–180. doi: 10.1080/00034983.1996.11813041 [DOI] [PubMed] [Google Scholar]
  • 49.Booth M, Mayombana C, Kilima P. The population biology and epidemiology of schistosome and geohelminth infections among schoolchildren in Tanzania. Trans R Soc Trop Med Hyg. 1998;92: 491–495. doi: 10.1016/s0035-9203(98)90886-0 [DOI] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009628.r001

Decision Letter 0

Mike J Doenhoff, Christine M Budke

23 Mar 2021

Dear Dr Ojurongbe,

Thank you very much for submitting your manuscript "Epidemiology of mixed urogenital and intestinal schistosomiasis among school children in two endemic communities of Southern Nigeria" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Mike J Doenhoff

Associate Editor

PLOS Neglected Tropical Diseases

Christine Budke

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The methods used are ok, but my worry is on the sample collection.

Reviewer #2: The objectives of the study are not clear.

In the methods, the authors do not explain why the study was conducted only in school children. In the results, two groups are presented according to age, but in the methods this division is not presented.

The collection of only one urine sample and one stool sample for each student may have limited the finding of positive samples in the study: why is this point not discussed by the authors?

The samples were collected from two communities, but the results are presented as a single sample. What is the reason for this choice? Was the prevalence similar in both communities? For both species of Schistosoma?

In the statistical analysis, was a normality test applied to the sample to choose the appropriate comparison test between the variables.

It is known that the intensity of schistosoma infection is affected by different factors, and not just age and sex. Variables such as hygiene habits, number and time of exposure to water collections, sanitation, previous infection and previous parasitic treatment, could also have been analyzed in the epidemiological study. Why were they not analyzed?

The absence of morbidity analysis in co-infection is a limiting factor in the study.

The authors gave no information about the study period.

Reviewer #3: The objectives of the study are not clearly articulated

The study design is not described

Though the sample size is big enough, the population is only partially described

the sample size is big enough

The statistical analysis is not appropriately reported

There are no ethical issues

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The analysis are okay and the results presented well. The issue is on the signs on table 2 which were not explained

Reviewer #2: The figures shown are not in high resolution. The variables that present significant results could be presented in the figure itself and not in the legend.

Table 3 is confused for the interpretation of the results.

It is necessary to explain the set of abbreviations: 'ectopic Sm/Sh' and 'ectopic Sm/Sh/Sm'

Reviewer #3: No specific comments

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Authors should remove sections on hybridization as pointed out in the text

All my other comments are inserted as notes in the text

Reviewer #2: When introducing the manuscript, the authors point out that hybridization between schistosoma species has not yet been reported in Africa (line 79). However, in lines 238 and 239 of the discussion, they present 2 studies that report the ectopic presence of schistosoma eggs in Cameroon (reference 14) and Senegal (reference 33). It may therefor be appropriate to rewrite the introduction paragraph.

The discussion of the article should be reviewed. It is superficial and limited.

At the beginning of the article, the authors suggest that the encounter of ectopic eggs is unprecedented in the study area. But throughout the article, there is decreasing emphasis on this observation and the discussion does not present a differential result. If it is really an unprecedented result, I recommend modifying the article to highlight this finding.

As this is an epidemiological study, it would be interesting to add a paragraph on the importance of the findings for local public health, according to the guidelines for coping with schistosomiasis as an important public health problem by the WHO.

Reviewer #3: The limitations are not clearly described

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Minor revision

Reviewer #2: (No Response)

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The study is good and deserves publication, however the authors should revise the use of words "impact" since the study is basically about prevalence

Reviewer #2: (No Response)

Reviewer #3: The manuscript entitled "Epidemiology of mixed urogenital and intestinal schistosomiasis among school children in two endemic communities of Southern Nigeria"submitted by Ojo et al. is important, and could give insight into the Schistosomiasis control challenges in areas where both major species are endemic.

However, the manuscript has a substantial limitations which the authors have to address prior any further consideration.

While the title clearly indicates an epidemiological study, there is no clear study design and nor any sampling frame which may permit a validation of the findings. The sites description indicated a previous study reporting the presence of S. hematobium, in urine and not the S. mansoni species. The statistical test used to test association, is not reported appropriately. All together the manuscript requires a deep revision.

In details:

Abstract section:

It is not clear what the authors called "ectopic egg": for non experts in schistosomiasis a brief explanation is required here.

The study design and methodology are missing, as well as brief study procedures, as appropriate in the Abstract.

Prevalence and intensity are confusedly reported and should be separated.

Would hematuria have been associated with S. hematobium?

Introduction Section:

• There is poor background information regarding clinical or epidemiological consequences of co-infection of S.h /S.m as well as ectopic eggs. Please provide more information to justify the research question.

MM section:

• Study design is missing

• Sample size calculation and sample collection should be separated

• Study procedure as well as inclusion and exclusion criteria are missing

• While the sample size calculated was 289, the authors recruited 466 participants: is there an explanation?

• Is there any reason for use of sterile container to collect stool and urine?

Results section:

• What does '5gm' mean?

• Will mixed infection Sh/Sm differ from Sm/Sh?

• Can author provide the odds CI:95% of hematuria in S.h positive versus S.h negative?

Discussion Section

1. Authors should cross check the p-value which should be <0.05 instead of >0.05

2. Authors should provide more specific information on lower liver morbidity and higher bladder morbidity

3. What do the authors mean by this: "Consequently, the collection of urine specimens and their examination may not be necessary in the classification of communities according to the level of endemicity of urinary schistosomiasis".?

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof Sammy Olufemi Sam-Wobo

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see https://journals.plos.org/plosntds/s/submission-guidelines#loc-methods

Attachment

Submitted filename: Reviewer - PNTD-D-20-01655_reviewer.pdf

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009628.r003

Decision Letter 1

Mike J Doenhoff, Christine M Budke

11 Jun 2021

Dear Dr Ojurongbe,

Thank you very much for submitting your manuscript "Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

The authors have made extensive amendments to the manuscript, following referees' suggestions.

I have re-read the manuscript and incorporated/suggested a few minor alterations, most of which can probably be attended to in-house.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Mike J Doenhoff

Associate Editor

PLOS Neglected Tropical Diseases

Christine Budke

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

The authors have made extensive amendments to the manuscript, following referees' suggestions.

I have re-read the manuscript and incorporated/suggested a few minor alterations, most of which can probably be attended to in-house.

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

Attachment

Submitted filename: Ojo et al_Revised_Changes highlited.docx

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009628.r005

Decision Letter 2

Mike J Doenhoff, Christine M Budke

5 Jul 2021

Dear Dr Ojurongbe,

We are pleased to inform you that your manuscript 'Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Mike J Doenhoff

Associate Editor

PLOS Neglected Tropical Diseases

Christine Budke

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009628.r006

Acceptance letter

Mike J Doenhoff, Christine M Budke

19 Jul 2021

Dear Dr Ojurongbe,

We are delighted to inform you that your manuscript, "Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Reviewer - PNTD-D-20-01655_reviewer.pdf

    Attachment

    Submitted filename: Response to reviwers comments.docx

    Attachment

    Submitted filename: Ojo et al_Revised_Changes highlited.docx

    Attachment

    Submitted filename: Response to reviwers comments_Minor V2.docx

    Data Availability Statement

    The data is available at https://data.mendeley.com/datasets/ddn8k3b5jj/1 doi: 10.17632/ddn8k3b5jj.1.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES